We are live on ! Find out more
BAM

Bellevue Asset Management Portfolio holdings

AUM $217M
1-Year Est. Return 14.36%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+14.36%
3 Year Est. Return
+56.75%
5 Year Est. Return
+72.55%
10 Year Est. Return
AUM
$163M
AUM Growth
+$20.4M
Cap. Flow
-$565K
Cap. Flow %
-0.35%
Top 10 Hldgs %
54.95%
Holding
673
New
65
Increased
101
Reduced
187
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 36.62%
2 Consumer Discretionary 10.82%
3 Healthcare 5.59%
4 Financials 3.43%
5 Consumer Staples 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMC icon
551
Vulcan Materials
VMC
$36.9B
$3K ﹤0.01%
20
-2
-9% -$285
VNT icon
552
Vontier
VNT
$4.74B
$3K ﹤0.01%
+96
New +$2.96K
VTWO icon
553
Vanguard Russell 2000 ETF
VTWO
$17.9B
$3K ﹤0.01%
32
-52
-62% -$3.67K
WIX icon
554
WIX.com
WIX
$2.52B
$3K ﹤0.01%
11
-15
-58% -$3.95K
XLE icon
555
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$3K ﹤0.01%
144
XYZ
556
Block Inc
XYZ
$47.5B
$3K ﹤0.01%
+12
New +$2.34K
NARI
557
DELISTED
Inari Medical, Inc. Common Stock
NARI
$3K ﹤0.01%
+28
New +$1.98K
RVNC
558
DELISTED
Revance Therapeutics, Inc.
RVNC
$3K ﹤0.01%
123
+56
+84% +$1.45K
DCPH
559
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3K ﹤0.01%
58
-9
-13% -$533
DOOR
560
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$3K ﹤0.01%
+33
New +$3.21K
AYX
561
DELISTED
Alteryx Inc
AYX
$3K ﹤0.01%
27
+10
+59% +$1.26K
TWNK
562
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$3K ﹤0.01%
209
+33
+19% +$444
RETA
563
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3K ﹤0.01%
24
+1
+4% +$131
BKI
564
DELISTED
Black Knight, Inc. Common Stock
BKI
$3K ﹤0.01%
37
-1
-3% -$91
ZEN
565
DELISTED
ZENDESK INC
ZEN
$3K ﹤0.01%
19
-20
-51% -$2.48K
GBT
566
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3K ﹤0.01%
63
+2
+3% +$99
RDS.A
567
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3K ﹤0.01%
79
ACB
568
Aurora Cannabis
ACB
$185M
$2K ﹤0.01%
+18
New +$1.31K
ACGL icon
569
Arch Capital
ACGL
$33.6B
$2K ﹤0.01%
50
-3
-6% -$98
ALEC icon
570
Alector
ALEC
$199M
$2K ﹤0.01%
94
-35
-27% -$435
ALGN icon
571
Align Technology
ALGN
$12.3B
$2K ﹤0.01%
+3
New +$1.35K
AVNS
572
DELISTED
Avanos Medical
AVNS
$2K ﹤0.01%
50
AYTU icon
573
AYTU BioPharma
AYTU
$25.3M
$2K ﹤0.01%
13
BIPC icon
574
Brookfield Infrastructure
BIPC
$4.85B
$2K ﹤0.01%
38
BPMC
575
DELISTED
Blueprint Medicines
BPMC
$2K ﹤0.01%
19
-3
-14% -$316

Similar funds

Bellevue Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Bellevue Asset Management held 673 positions worth $163M, up 14% from $143M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Bellevue Asset Management's Q4 2020 filing shows 65 new, 101 increased, 187 reduced and 33 closed positions. Its largest new stake was Southwest Airlines: 5,129 shares worth $236K. The largest sale was Microsoft, an estimated $735K.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bellevue Asset Management's largest Q4 2020 buy was Southwest Airlines: 5,129 shares worth $236K.
  • Bellevue Asset Management added most to JPMorgan Diversified Return US Equity ETF in Q4 2020, an estimated $632K increase.
  • Bellevue Asset Management's biggest Q4 2020 reduction was Microsoft, cutting an estimated $735K.
  • Bellevue Asset Management fully exited Timberland Bancorp in Q4 2020, selling an estimated $212K.
  • Bellevue Asset Management's ten largest holdings make up 55% of its $163M portfolio in Q4 2020.
  • Bellevue Asset Management opened 65 new positions and closed 33 in Q4 2020.
  • Bellevue Asset Management's portfolio value rose 14% quarter-over-quarter to $163M.

Based on Bellevue Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.